Full details for Paige AI
JavaScript is off. The full description, available review and related listings are shown below.
Paige delivers advanced AI-powered digital pathology solutions designed to assist pathologists in cancer detection, diagnosis, and biomarker discovery. Its suite of applications, including Prostate, Breast, GI, and PanCancer Suites, leverages large-scale foundation models trained on millions of pathology slides. Paige's technology supports clinical workflows, research, and pharmaceutical development, enabling more efficient diagnostics and personalized cancer care across diverse tissue types.
Review
At a glance
Paige is a leader in AI-powered digital pathology, offering a suite of applications designed to support cancer detection, diagnosis, and research. Its technology leverages large-scale foundation models trained on millions of pathology slides, enabling pathologists and researchers to analyze tissue samples with greater efficiency and accuracy. Paige’s solutions are used in clinical, research, and pharmaceutical settings, supporting workflows across multiple tissue types and cancer subtypes. The platform is recognized for its regulatory achievements and strategic partnerships, which help expand access to advanced diagnostics globally.
Capabilities
Paige’s core capabilities include AI-assisted detection and diagnosis of cancer in tissue samples, biomarker discovery, and support for multi-modal patient outcome modeling. The platform offers specialized suites for prostate, breast, gastrointestinal, and pan-cancer applications, each designed to assist pathologists in identifying suspicious regions and classifying cancer types. Paige’s foundation models, such as Virchow2 and PRISM2, are trained on millions of whole-slide images and are compatible with modern language models, enabling integration with clinical language and workflows. The technology also supports pharmaceutical research by enabling cohort identification and biomarker prediction.
Workflow
Paige integrates into digital pathology workflows by providing AI-powered applications that analyze whole-slide images and generate clinically relevant insights. The platform can be embedded within laboratory information systems (LIS) and digital pathology infrastructures, as demonstrated by partnerships with companies like Lumea and ZayaAI. Paige’s applications can triage cases, prioritize suspicious slides for review, and streamline diagnostic processes. The Alba co-pilot, currently in beta, offers an interactive interface for pathologists, combining voice and text commands with real-time AI insights to further optimize workflow efficiency.
Strengths
Paige’s strengths lie in its use of large, diverse datasets for model training, regulatory clearances (including FDA approval for specific applications), and its ability to support a wide range of cancer types and tissue samples. The platform’s integration with LIS and digital pathology systems enhances accessibility and workflow efficiency. Strategic partnerships with healthcare providers and research organizations, such as NHS Wales and the Breast International Group, further validate the platform’s impact and reach. Paige’s technology is designed to be adaptable, supporting both clinical diagnostics and research applications.
Limitations
While Paige offers advanced AI-powered solutions, some features, such as the Alba co-pilot, are currently in beta and not yet commercially available. The deployment of certain applications may depend on regulatory approvals and integration with existing laboratory systems. Access to the full suite of features may require enterprise licensing or partnerships, and the platform’s effectiveness relies on the quality and compatibility of digital pathology infrastructure within healthcare organizations.
Best for
Paige is best suited for clinical pathology laboratories, research institutions, and pharmaceutical companies seeking to enhance cancer diagnostics and research with AI-powered tools. It is particularly valuable for organizations handling high volumes of pathology cases, those involved in biomarker discovery, and teams aiming to standardize and accelerate diagnostic workflows. The platform’s adaptability makes it suitable for both routine clinical use and advanced research projects.
Value and verdict
Paige stands out as a comprehensive AI-powered pathology platform, offering robust diagnostic and research capabilities supported by large-scale foundation models and regulatory achievements. Its integration with digital pathology systems and partnerships with leading healthcare organizations underscore its value in improving diagnostic accuracy, efficiency, and access to advanced cancer care. While some features are still in development, Paige’s current offerings provide significant benefits for pathologists and researchers, making it a strong choice for institutions seeking to leverage AI in cancer diagnostics.
Key features
- AI-assisted cancer detection and diagnosis
- Biomarker discovery
- Multi-tissue and multi-cancer support
- Integration with digital pathology systems
- Foundation models trained on millions of slides
- Support for clinical and research workflows
Explore AI tools
- Aidoc — Aidoc is a clinical AI platform that connects care teams and streamlines workflows across radiology, cardiology, neurovascular, and vascular specialties. (Healthcare, Free)
- Apple Health — Apple Health provides science-backed health insights and wellness tracking, prioritizing user privacy and integrating across Apple devices. (Healthcare, Freemium)
- Babylon Health — Babylon Health — AI-powered health consultations and symptom assessment platform (Healthcare, Free)
- BetterHelp — BetterHelp — Online counseling and therapy with licensed professionals (Healthcare, Paid)
- Buoy Health — Buoy Health — AI health assistant for symptom checking and care navigation (Healthcare, Freemium)
- Butterfly Network — Butterfly Network provides handheld, whole-body ultrasound probes with AI-powered imaging and workflow management for clinical and veterinary use. (Healthcare, Paid)
